An Active Immune Defense with a Minimal CRISPR ( C lustered R egularly I nterspaced S hort P alindromic R epeats) RNA and without the Cas6 Protein *
Journal of Biological Chemistry, ISSN: 0021-9258, Vol: 290, Issue: 7, Page: 4192-4201
2015
- 26Citations
- 69Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations26
- Citation Indexes26
- 26
- CrossRef24
- Captures69
- Readers69
- 69
Article Description
The prokaryotic immune system CRISPR-Cas ( c lustered r egularly i nterspaced s hort p alindromic r epeats- C RISPR- ass ociated) is a defense system that protects prokaryotes against foreign DNA. The short CRISPR RNAs (crRNAs) are central components of this immune system. In CRISPR-Cas systems type I and III, crRNAs are generated by the endonuclease Cas6. We developed a Cas6b-independent crRNA maturation pathway for the Haloferax type I-B system in vivo that expresses a functional crRNA, which we termed independently generated crRNA (icrRNA). The icrRNA is effective in triggering degradation of an invader plasmid carrying the matching protospacer sequence. The Cas6b-independent maturation of the icrRNA allowed mutation of the repeat sequence without interfering with signals important for Cas6b processing. We generated 23 variants of the icrRNA and analyzed them for activity in the interference reaction. icrRNAs with deletions or mutations of the 3′ handle are still active in triggering an interference reaction. The complete 3′ handle could be removed without loss of activity. However, manipulations of the 5′ handle mostly led to loss of interference activity. Furthermore, we could show that in the presence of an icrRNA a strain without Cas6b (Δ cas6b ) is still active in interference.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0021925819470087; http://dx.doi.org/10.1074/jbc.m114.617506; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84922767032&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/25512373; https://linkinghub.elsevier.com/retrieve/pii/S0021925819470087; http://www.jbc.org/lookup/doi/10.1074/jbc.M114.617506; https://syndication.highwire.org/content/doi/10.1074/jbc.M114.617506; https://dx.doi.org/10.1074/jbc.m114.617506
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know